Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Viggo F I, Van Tendeloo"'
Autor:
Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F. I. Van Tendeloo, Yiwei Chu, Zwi N. Berneman, Feifei Luo, Heleen H. Van Acker, Sébastien Anguille
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Chimeric antigen receptor (CAR)-modified T cell therapy is a rapidly emerging immunotherapeutic approach that is revolutionizing cancer treatment. The impressive clinical results obtained with CAR-T cell therapy in patients with acute lymphoblastic l
Externí odkaz:
https://doaj.org/article/49a4a6c44b2845dd97520781fda0d3e9
Autor:
Diana Campillo-Davo, Maxime De Laere, Gils Roex, Maarten Versteven, Donovan Flumens, Zwi N. Berneman, Viggo F. I. Van Tendeloo, Sébastien Anguille, Eva Lion
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 396 (2021)
Messenger RNA (mRNA) electroporation is a powerful tool for transient genetic modification of cells. This non-viral method of genetic engineering has been widely used in immunotherapy. Electroporation allows fine-tuning of transfection protocols for
Externí odkaz:
https://doaj.org/article/54fd5dcca621443087718cd1a5b2ab14
Autor:
Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo, Eva Lion
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Two decades of clinical cancer research with dendritic cell (DC)-based vaccination have proved that this type of personalized medicine is safe and has the capacity to improve survival, but monotherapy is unlikely to cure the cancer. Designed to empow
Externí odkaz:
https://doaj.org/article/9d620992a252497bba02d6bf5337af30
Autor:
Zwi N. Berneman, Sanne van der Heijden, Gils Roex, Diana Campillo-Davo, Maarten Versteven, Sébastien Anguille, Eva Lion, Hans De Reu, Viggo F I Van Tendeloo
Publikováno v:
Cancers, Vol 12, Iss 2, p 256 (2020)
Cancers
Volume 12
Issue 2
Cancers
Volume 12
Issue 2
The functional avidity of T-cell receptor (TCR)-engineered T cells towards their cognate epitope plays a crucial role in successfully targeting and killing tumor cells expressing the tumor-associated antigen (TAA). When evaluating in vitro functional
Autor:
Ellen Van Gulck, Nathalie Cools, Derek Atkinson, Lotte Bracke, Katleen Vereecken, Marc Vekemans, Viggo F. I. Van Tendeloo, Zwi N. Berneman, Guido Vanham
Publikováno v:
Clinical and Developmental Immunology, Vol 2012 (2012)
A variety of immune-based therapies has been developed in order to boost or induce protective CD8+ T cell responses in order to control HIV replication. Since dendritic cells (DCs) are professional antigen-presenting cells (APCs) with the unique capa
Externí odkaz:
https://doaj.org/article/4f4ef63f4f194d7eb9a4193900256c44
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20952 (2011)
α active specific immunotherapy aims at stimulating the host's immune system to recognize and eradicate malignant cells. The concomitant activation of dendritic cells (DC) and natural killer (NK) cells is an attractive modality for immune-based ther
Externí odkaz:
https://doaj.org/article/af87beb1555644ce8817074f2c6565a6
Publikováno v:
Clinical and Developmental Immunology, Vol 2007 (2007)
Externí odkaz:
https://doaj.org/article/74396b3edba14bfe8cd6008375f19138
Autor:
Zoë P. Van Acker, Daniela Pende, Evelien Smits, Peter Ponsaerts, Zwi N. Berneman, Maarten Versteven, Sébastien Anguille, Viggo F I Van Tendeloo, Heleen H. Van Acker
Publikováno v:
Cancers, Vol 11, Iss 7, p 1029 (2019)
Cancers
Volume 11
Issue 7
Cancers
Volume 11
Issue 7
A particularly interesting marker to identify anti-tumor immune cells is the neural cell adhesion molecule (NCAM), also known as cluster of differentiation (CD)56. Namely, hematopoietic expression of CD56 seems to be confined to powerful effector imm
Autor:
Marion Subklewe, Sébastien Anguille, Eva Lion, Zwi N. Berneman, Diana Campillo-Davo, Heleen H. Van Acker, Gils Roex, Viggo F I Van Tendeloo, Felix S. Lichtenegger, Maarten Versteven
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 5, p 579 (2019)
Journal of Clinical Medicine
Journal of Clinical Medicine
Acute myeloid leukemia (AML) is a type of blood cancer characterized by the uncontrolled clonal proliferation of myeloid hematopoietic progenitor cells in the bone marrow. The outcome of AML is poor, with five-year overall survival rates of less than
Autor:
Maxime De Laere, Diana Campillo-Davo, Maarten Versteven, Zwi N. Berneman, Gils Roex, Sébastien Anguille, Donovan Flumens, Eva Lion, Viggo F I Van Tendeloo
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 396, p 396 (2021)
Pharmaceutics, Vol 13, Iss 396, p 396 (2021)
Messenger RNA (mRNA) electroporation is a powerful tool for transient genetic modification of cells. This non-viral method of genetic engineering has been widely used in immunotherapy. Electroporation allows fine-tuning of transfection protocols for